European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas

European drugmakers on Monday announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums. Anglo-Swedish AstraZeneca AZN, +1.42%   AZN, -1.26% said it’s pay...

Takeda says drugmakers could cut prices in face of global crises

The head of Asia’s largest pharmaceutical company said the risk of a global recession, along with the impact of Covid-19 and the war in Ukraine, could force the industry to cut drug prices. Christophe...

Pair of Drugmakers Soar in Meme-Like Session on Study Results

(Bloomberg) — Two biopharmaceutical companies enjoyed a meme-like day on Monday, surging at least twofold on promising results. Most Read from Bloomberg Veru Inc. more than tripled intraday in i...